EarningsQ2 2023 Earnings Report

Percheron Therapeutics (PERCF) Q2 2023 Earnings Report

13 Followers

PERCF Q2 2023 EPS Results

Actual EPS>-$0.01

Consensus EPS>-$0.01

Beat/MissBeat by +<$0.01

One Year Ago EPS>-$0.01

Actual Revenue$0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ2 2023

Date02/22/2023

TimeBefore Open

Conference CallWednesday, February 22, 2023

PERCF Upcoming Earnings

Percheron Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Feb 24, 2027	2027 (Q2)	- / -	-0.002	―
Aug 19, 2026	2026 (Q4)	- / >-0.01	-0.004	83.33% (<+0.01)
Feb 26, 2026	2026 (Q2)	- / >-0.01	-0.006	66.67% (<+0.01)
Aug 28, 2025	2025 (Q4)	- / >-0.01	-0.006	25.00% (<+0.01)
Feb 19, 2025	2025 (Q2)	-0.01 / >-0.01	-0.004	-50.00% (>-0.01)
Aug 29, 2024	2024 (Q4)	>-0.01 / >-0.01	-0.006	11.11% (<+0.01)
Feb 28, 2024	2024 (Q2)	>-0.01 / >-0.01	-0.006	25.00% (<+0.01)
Aug 25, 2023	2023 (Q4)	-0.01 / >-0.01	-0.003	-125.00% (>-0.01)
Feb 22, 2023	2023 (Q2)	>-0.01 / >-0.01	-0.004	-60.00% (>-0.01)
Aug 31, 2022	2022 (Q4)	-0.01 / >-0.01	-0.008	63.64% (<+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed